Related Experiment Video
Updated: Jun 26, 2026

Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures
Published on: March 20, 2019
Axonal protective effects of the myelin-associated glycoprotein
Thien Nguyen1, Niraj R Mehta, Katherine Conant
1Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. tnguyena@jhmi.edu
Abstract:
Progressive axonal degeneration follows demyelination in many neurological diseases, including multiple sclerosis and inherited demyelinating neuropathies, such as Charcot-Marie-Tooth disease. One glial molecule, the myelin-associated glycoprotein (MAG), located in the adaxonal plasmalemma of myelin-producing cells, is known to signal to the axon and to modulate axonal caliber through phosphorylation of axonal neurofilament proteins. This report establishes for the first time that MAG also promotes resistance to axonal injury and prevents axonal degeneration both in cell culture and in vivo. This effect on axonal stability depends on the RGD domain around arginine 118 in the extracellular portion of MAG, but it is independent of Nogo signaling in the axon. Exploiting this pathway may lead to therapeutic strategies for neurological diseases characterized by axonal loss.
Insights
Myelin-associated glycoprotein (MAG) protects axons from degeneration in neurological diseases. This discovery offers new therapeutic strategies for conditions involving axonal loss.
Area of Science:
- Neuroscience
- Cell Biology
- Neuropathology
Background:
- Demyelinating diseases like multiple sclerosis and Charcot-Marie-Tooth disease involve progressive axonal degeneration.
- Myelin-associated glycoprotein (MAG) is a glial molecule that signals to axons and modulates axonal caliber.
Purpose of the Study:
- To investigate the role of MAG in promoting axonal resistance to injury and degeneration.
- To determine the specific domains and signaling pathways involved in MAG's neuroprotective effects.
Main Methods:
- Cell culture experiments to assess MAG's effect on axonal stability.
- In vivo studies to confirm MAG's role in preventing axonal degeneration.
- Analysis of MAG's extracellular RGD domain and its independence from Nogo signaling.
Main Results:
- MAG significantly promotes axonal resistance to injury and prevents axonal degeneration in both cell culture and in vivo models.
- This neuroprotective effect is dependent on the RGD domain within the extracellular portion of MAG.
- The protective function of MAG is independent of Nogo signaling pathways.
Conclusions:
- MAG plays a crucial role in maintaining axonal stability and preventing degeneration, independent of Nogo signaling.
- The RGD domain of MAG is critical for its neuroprotective function.
- Targeting the MAG pathway presents a promising therapeutic strategy for neurological disorders characterized by axonal loss.
More Related Videos
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Action Potentials
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Neurogenesis and Regeneration of Nervous Tissue